Cancer death rates for older Asian-Americans: classification by race versus ethnicity.
Cancer death rates for older Asian-Americans: classification by race versus ethnicity.
复制标题
老年亚裔美国人的癌症死亡率：按种族与民族分类。
DOI：
10.1007/s10552-007-9079-4
复制
发表时间：
2008
期刊：
影响因子：
--
通讯作者：
Huo,Dezheng
中科院分区：
文献类型：
--
作者：
Lauderdale,DianeS;Huo,Dezheng
对于大多数美国健康统计数据，亚裔美国人被归为一个种族类别。我们使用一个独特的数据文件来确定六个亚裔美国人种族亚组中65岁及以上人群的特定部位癌症死亡率（中国人、印度人、日本人、韩国人、菲律宾人和越南人），并确定亚裔美国人种族类别的总和对亚组癌症风险的误导性总结。与社会保障局的同事合作。通过将这些记录与死亡证明联系起来，我们确定了21个癌症部位的特定原因死亡率。我们测试是否有亚组之间的显着异质性，使用Poisson regression.ResultsFor约一半的癌症部位，所有亚洲亚组有较低的利率比白人。对于三个部位，大多数亚组的发生率高于白人（胃、肝和宫颈），但存在显著异质性。对于其他癌症部位，有一个不一致的模式，一些亚组的发病率低于白人，一些亚组的发病率与白人相似。亚裔印度人是最经常的亚洲亚组与一个分歧率。ConclusionThe总亚裔美国人的速度掩盖了许多，但不是所有的癌症部位显着的亚组异质性。
ObjectiveFor most US health statistics, Asian-Americans are grouped into a single race category. We use a unique data file to determine site-specific cancer death rates for persons aged 65 and older in six Asian-American ethnic subgroups (Chinese, Indian, Japanese, Korean, Filipino, and Vietnamese) and determine for which cancer sites the aggregate Asian-American race category is a misleading summary of subgroup cancer risk.MethodsWe previously determined all-cause death rates for Asian-American subgroups using Social Security files, in collaboration with a colleague at the Social Security Administration. By linking these records to death certificates, we determine cause-specific death rates for 21 cancer sites. We test whether there is significant heterogeneity among subgroups, using Poisson regression.ResultsFor about half of cancer sites, all Asian subgroups have lower rates than Whites. For three sites most subgroups have higher rates than Whites (stomach, liver, and cervix), but there is significant heterogeneity. For other cancer sites, there is an inconsistent pattern, with some subgroups having rates lower than Whites and some having rates similar to Whites. Asian Indians are most often the Asian subgroup with a divergent rate.ConclusionThe aggregate Asian-American rate masks significant subgroup heterogeneity for many, but not all, cancer sites.